Cardiome Pharma (CRME) Jumps: Stock Moves 8.1% Higher

Cardiome Pharma Corp. CRME was a big mover last session, as its shares rose over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This also led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.35 to $5.01 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive and one negative estimate revision. Meanwhile, the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday's jump can turn into more strength down the road.

Cardiome Pharma currently has a Zacks Rank #3 (Hold).

A better-ranked med-drugs stock is Juniper Pharmaceuticals, Inc. JNP which sports a Zacks Rank #1 (Strong Buy).

Is CRME going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CARDIOME PHARMA CRME: Free Stock Analysis Report
 
JUNIPER PHARMA (JNP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research